uniQure (QURE) Return on Capital Employed (2017 - 2026)
uniQure's (QURE) quarterly Return on Capital Employed came in at 25.82% in Q1 2026, up 528.0% year-on-year from 4.11% in Q1 2025, and down 10.57% quarter-over-quarter from 23.35% in Q4 2025.
uniQure (QURE) Return on Capital Employed (2017 - 2026) Analysis & Trends
uniQure's Return on Capital Employed history runs 10 years deep, the most recent figure standing at 25.82% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 528.0% year-over-year to 25.82% in Q1 2026; TTM through Mar 2026 was 25.82%, a 528.0% increase from a year earlier, with the FY2025 full-year figure at 29.52%, down 135.0% from the prior year.
- Return on Capital Employed slipped to 25.82% in Q1 2026 per QURE's latest filing, from 23.35% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 40.76% in Q1 2022 and bottomed at 36.36% in Q4 2023.
- The 5-year median for Return on Capital Employed is 27.67% (2022), against an average of 24.72%.
- Biggest YoY gain for Return on Capital Employed was 8308 bps in 2022; the steepest drop was 7945 bps in 2022.
- Year by year, Return on Capital Employed stood at 24.03% in 2022, then sank by 51 bps to 36.36% in 2023, then gained by 10 bps to 32.84% in 2024, then grew by 29 bps to 23.35% in 2025, then retreated by 11 bps to 25.82% in 2026.
- Per Business Quant, the three latest QURE Return on Capital Employed figures stand at 25.82% (Q1 2026), 23.35% (Q4 2025), and 28.31% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | -25.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.82% |
| Dec 31, 2025 | -23.35% |
| Sep 30, 2025 | -28.31% |
| Jun 30, 2025 | -30.54% |
| Mar 31, 2025 | -31.10% |
| Dec 31, 2024 | -32.84% |
| Sep 30, 2024 | -32.45% |
| Jun 30, 2024 | -36.10% |
| Mar 31, 2024 | -35.66% |
| Dec 31, 2023 | -36.36% |
| Sep 30, 2023 | -23.21% |
| Jun 30, 2023 | -23.97% |
| Mar 31, 2023 | -27.13% |
| Dec 31, 2022 | -24.03% |
| Sep 30, 2022 | -27.67% |
| Jun 30, 2022 | -22.48% |
| Mar 31, 2022 | 40.76% |
| Dec 31, 2021 | 41.13% |
| Sep 30, 2021 | 40.72% |
| Jun 30, 2021 | 56.97% |